Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studies

BACKGROUND: Two replicate, double-blind, placebo-controlled, 6-week crossover studies assessed the effect of the once-daily long-acting β(2)-agonist olodaterol 5 μg and 10 μg on constant work-rate cycle endurance in patients with moderate to very severe chronic obstructive pulmonary disease. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Maltais, François, Kirsten, Anne-Marie, Hamilton, Alan, De Sousa, Dorothy, Voß, Florian, Decramer, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936013/
https://www.ncbi.nlm.nih.gov/pubmed/27383762
http://dx.doi.org/10.1186/s12931-016-0389-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936013/
https://www.ncbi.nlm.nih.gov/pubmed/27383762
http://dx.doi.org/10.1186/s12931-016-0389-5

Ejemplares similares